Prevalence of autoimmune conditions in pregnant women in a tertiary maternity hospital: A cross-sectional survey and maternity database review.

Australia Autoimmune disease autoimmunity pregnancy prevalence

Journal

Obstetric medicine
ISSN: 1753-495X
Titre abrégé: Obstet Med
Pays: England
ID NLM: 101464191

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 31 07 2020
revised: 09 09 2020
accepted: 16 09 2020
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 15 10 2021
Statut: ppublish

Résumé

Autoimmune conditions are associated with adverse pregnancy and offspring outcomes; however, the prevalence in pregnant women is not well understood. Estimates based on administrative data alone may underestimate prevalence. A cross-sectional survey of women attending a tertiary referral hospital for antenatal care in December 2018-February 2019 and review of the hospital's maternity database of women giving birth from October 2017-June 2018 to estimate autoimmune disease prevalence. A total of 400 women completed surveys (78% response rate) and 41 (10.3%) reported an autoimmune disease, most commonly Hashimoto's thyroiditis (2.8%) and psoriasis (2.5%). From the maternity database, 112 of 2756 women giving birth (4.1%) had a recorded autoimmune disease, most commonly Hashimoto's thyroiditis (1.3%) followed by coeliac disease, Graves' disease, and immune thrombocytopenic purpura (all 0.4%). Autoimmune disease prevalence in pregnant women is higher when self-reported and may be more common than previously reported using administrative data.

Sections du résumé

BACKGROUND BACKGROUND
Autoimmune conditions are associated with adverse pregnancy and offspring outcomes; however, the prevalence in pregnant women is not well understood. Estimates based on administrative data alone may underestimate prevalence.
METHODS METHODS
A cross-sectional survey of women attending a tertiary referral hospital for antenatal care in December 2018-February 2019 and review of the hospital's maternity database of women giving birth from October 2017-June 2018 to estimate autoimmune disease prevalence.
RESULTS RESULTS
A total of 400 women completed surveys (78% response rate) and 41 (10.3%) reported an autoimmune disease, most commonly Hashimoto's thyroiditis (2.8%) and psoriasis (2.5%). From the maternity database, 112 of 2756 women giving birth (4.1%) had a recorded autoimmune disease, most commonly Hashimoto's thyroiditis (1.3%) followed by coeliac disease, Graves' disease, and immune thrombocytopenic purpura (all 0.4%).
CONCLUSION CONCLUSIONS
Autoimmune disease prevalence in pregnant women is higher when self-reported and may be more common than previously reported using administrative data.

Identifiants

pubmed: 34646344
doi: 10.1177/1753495X20964680
pii: 10.1177_1753495X20964680
pmc: PMC8504298
doi:

Types de publication

Journal Article

Langues

eng

Pagination

158-163

Informations de copyright

© The Author(s) 2020.

Références

Lancet Diabetes Endocrinol. 2018 Jul;6(7):575-586
pubmed: 29246752
J Rheumatol. 2017 Aug;44(8):1134-1141
pubmed: 28412703
Lancet Diabetes Endocrinol. 2013 Nov;1(3):228-37
pubmed: 24622371
Ann Rheum Dis. 2013 Apr;72(4):547-51
pubmed: 22753385
Autoimmun Rev. 2012 Aug;11(10):754-65
pubmed: 22387972
Nat Commun. 2019 Sep 20;10(1):4295
pubmed: 31541153
Arthritis Care Res (Hoboken). 2014 Nov;66(11):1710-7
pubmed: 24757083
BMJ Open. 2016 Jan 25;6(1):e009494
pubmed: 26810997
PLoS One. 2019 May 29;14(5):e0216526
pubmed: 31141520
Joint Bone Spine. 2018 Oct;85(5):599-603
pubmed: 29183859
J Matern Fetal Neonatal Med. 2020 Feb;33(4):618-624
pubmed: 30189769
J Rheumatol. 2017 Aug;44(8):1109-1111
pubmed: 28765344
Autoimmun Rev. 2016 Oct;15(10):975-7
pubmed: 27481037
Autoimmun Rev. 2003 May;2(3):119-25
pubmed: 12848952
Pediatr Rheumatol Online J. 2018 Apr 16;16(1):26
pubmed: 29661199
Rheum Dis Clin North Am. 2017 May;43(2):263-273
pubmed: 28390568
CMAJ Open. 2017 Sep 25;5(3):E729-E733
pubmed: 28947426
JAMA. 2018 Jul 3;320(1):89-91
pubmed: 29936530
Biol Psychiatry. 2017 Mar 1;81(5):452-459
pubmed: 26809250
Lancet Diabetes Endocrinol. 2013 Nov;1(3):238-49
pubmed: 24622372
J Autoimmun. 2009 Nov-Dec;33(3-4):197-207
pubmed: 19819109
J Matern Fetal Neonatal Med. 2020 Sep 13;:1-9
pubmed: 32924679
Clin Rev Allergy Immunol. 2018 Dec;55(3):239-253
pubmed: 30051260
J Autoimmun. 2019 Sep;103:102287
pubmed: 31147159
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Am J Public Health. 2010 Nov;100(11):2279-87
pubmed: 20864721
Clin Immunol Immunopathol. 1997 Sep;84(3):223-43
pubmed: 9281381
J Autoimmun. 2007 Aug;29(1):1-9
pubmed: 17582741
J Womens Health (Larchmt). 2013 Jul;22(7):578-86
pubmed: 23829184

Auteurs

Jacqueline R Lim (JR)

Sydney Medical School, The University of Sydney, Sydney, Australia.

Timothy C Nielsen (TC)

Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Russell C Dale (RC)

Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Hannah F Jones (HF)

Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Amanda Beech (A)

Department of Endocrinology/Obstetric Medicine, Royal Hospital for Women, Sydney, Australia.

Natasha Nassar (N)

Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Samantha J Lain (SJ)

Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Antonia Shand (A)

Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Department of Maternal Fetal Medicine, Royal Hospital for Women, Sydney, Australia.

Classifications MeSH